Showing results (631-640 of 1,093) with videos related to

Sort By:
Pageof 110
JPMA. the Journal of the Pakistan Medical Association|March 27, 2025
Optimizing Kidney Disease Management during Ramadan: Evidence-Based Risk Stratification and Tailored StrategiesSourabh Sharma, Manisha Sahay, Mastakim Ahmed Mazumder, et al.
Frontiers in Neuroscience|April 12, 2016
Cerebral Degeneration in Amyotrophic Lateral Sclerosis Revealed by 3-Dimensional Texture AnalysisRouzbeh Maani, Yee-Hong Yang, Derek Emery, et al.
Indian Journal of Endocrinology and Metabolism|May 30, 2017
An Audit of Insulin Usage and Insulin Injection Practices in a Large Indian CohortManash P Baruah, Sanjay Kalra, Saptarshi Bose, et al.
Indian Heart Journal|August 21, 2016
Cardiovascular outcome trials for anti-diabetes medication: A holy grail of drug development?Mathew John, Ambika Gopalakrishnan Unnikrishnan, Sanjay Kalra, et al.
JPMA. the Journal of the Pakistan Medical Association|July 23, 2025
The 5C model: Clinical approach to peripheral neuropathySanjay Kalra, Atul Dhingra, Suneet Kumar Verma, et al.
Indian Journal of Endocrinology and Metabolism|April 4, 2025
Endocrinology and Supernatural Beliefs; A ReviewJaideep Khare, Preeti S Pendharkar, Sanjay Kalra, et al.
Current Diabetes Reviews|January 10, 2023
Use of Second-Generation Basal Insulin Gla-300 in Special Populations: A Narrative Mini-ReviewSujoy Ghosh, Sanjay Kalra, Ganapathi Bantwal, et al.
Indian Journal of Endocrinology and Metabolism|February 16, 2019
Sodium-glucose Cotransporter-2 Inhibitors in Combination with Other Glucose-lowering Agents for the Treatment of Type 2 Diabetes MellitusSanjay Kalra, Jothydev Kesavadev, Manoj Chadha, et al.
Indian Journal of Endocrinology and Metabolism|February 16, 2019
Genital Infections with Sodium Glucose Cotransporter-2 Inhibitors: Occurrence and Management in Patients with Type 2 Diabetes MellitusA G Unnikrishnan, Sanjay Kalra, Vedavati Purandare, et al.
Endocrinology, Diabetes & Metabolism|December 2, 2021
One-year trends from the LANDMARC trial: A 3-year, pan-India, prospective, longitudinal study on the management and real-world outcomes of type 2 diabetes mellitusAshok K Das, Sanjay Kalra, Shashank Joshi, et al.
Pageof 110